Which therapeutic measures does Cryoprecipitate provide?

Cryoprecipitate is a blood product that is particularly rich in certain clotting factors, which are essential for effective hemostasis. The primary constituents of cryoprecipitate include fibrinogen, factor VIII, and von Willebrand factor.

Fibrinogen is a protein crucial for the blood clotting process, as it is converted into fibrin, forming the mesh that stabilizes a clot. Factor VIII plays a significant role in blood coagulation and is particularly important in the management of hemophilia A. This combination of fibrinogen and factor VIII allows cryoprecipitate to be especially useful in treating hypofibrinogenemia and bleeding disorders.

In the context of the question, selecting the option that identifies fibrinogen and factor VIII accurately reflects the therapeutic measures provided by cryoprecipitate. This makes it a vital component in scenarios requiring rapid hemostatic improvement, such as in trauma or surgical patients experiencing significant blood loss.